Oral vinorelbine/paclitaxel combination treatment of metastatic breast cancer: a phase I study R. DelvaT. PienkowskiI. Douville Original Article 22 September 2006 Pages: 703 - 709
Platinum drug effects on the expression of genes in the polyamine pathway: time-course and concentration-effect analysis based on Affymetrix gene expression profiling of A2780 ovarian carcinoma cells Ram VarmaSuzanne HectorLakshmi Pendyala Original Article 22 September 2006 Pages: 711 - 723
Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth Timothy J. JorgensenHui TianDavid Frost Original Article 12 September 2006 Pages: 725 - 732
The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines Yuji ToiyamaYasuhiro InoueMasato Kusunoki Original Article 07 September 2006 Pages: 733 - 742
Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates Stacey L. BergClaudia BruecknerSusan M. Blaney Original Article 05 September 2006 Pages: 743 - 747
Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines Julie ScottRobert T. DorrTerry H. Landowski Original Article 28 February 2007 Pages: 749 - 757
Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride Jens TeichertFrank BaumannRainer Preiss Original Article 07 September 2006 Pages: 759 - 770
High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study Alessandra TedeschiMarco MontilloEnrica Morra Original Article 26 January 2007 Pages: 771 - 779
The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines Elizabeth K. Balcer-KubiczekMona AttarpourMartin J. Edelman Original Article 07 September 2006 Pages: 781 - 787
Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck Hideaki KatoriMamoru TsukudaTakahide Taguchi Original Article 20 October 2006 Pages: 789 - 794
Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models Kaori Fujimoto-OuchiFumiko SekiguchiYutaka Tanaka Original Article 10 October 2006 Pages: 795 - 805
Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models Kaori Fujimoto-OuchiEtsuro OnumaYutaka Tanaka Original Article 29 September 2006 Pages: 807 - 815
Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma David E. GerberStuart A. GrossmanXiaobu Ye Original Article 14 September 2006 Pages: 817 - 823
Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancer Jan H. BeumerJeany M. Rademaker-LakhaiJos H. Beijnen Original Article 20 September 2006 Pages: 825 - 837
Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks Weiguang WangHoward L. McLeodElaina S. R. Collie-Duguid Original Article 22 November 2006 Pages: 839 - 845
Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia Patrick A. ThompsonDaryl J. MurryLisa R. Bomgaars Original Article 29 November 2006 Pages: 847 - 853
The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate Roos L. OostendorpSerena MarchettiJan H. M. Schellens Short Communication 16 December 2006 Pages: 855 - 860
